Moderna, Exxon, Alphabet, Amazon: Stocks That Defined the Week

Moderna, Exxon, Alphabet, Amazon: Stocks That Defined the Week

Moderna Inc. U.S. health regulators late Friday permitted use of Moderna's Covid-19 vaccine, the second shot to get the green light to help end the pandemic. The Food and Drug Administration's authorization comes a week after the agency authorized the first shot in the U.S., from Pfizer Inc. and its partner BioNTech SE. Moderna, a ten-year-old biotech that has never had a product cleared by the FDA, expects to deliver a total of 20 million doses by the end of December. Moderna shares rose 5.1% Thursday when an advisory panel cleared the way for Friday night's authorization.

Exxon Mobil Corp. Exxon is going green(ish). The Texas-based oil giant pledged Monday to reduce greenhouse-gas emissions from its operations over the next five years and eliminate routine flaring, or burning, of methane from its oil-and-gas operations in the next decade. “We respect and support society's ambition to achieve net zero emissions by 2050, and continue to advocate for policies that promote cost-effective, market-based solutions to address the risks of climate change,” Exxon Chief Executive Darren Woods said. The targets stop short of pledges by European peers, including